OrthoPediatrics Corp. (KIDS)

Market Cap	413.02M
Revenue (ttm)	227.41M
Net Income (ttm)	-45.61M
Shares Out	25.08M
EPS (ttm)	-1.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195,809
Open	16.50
Previous Close	16.46
Day's Range	16.15 - 16.94
52-Week Range	15.28 - 32.00
Beta	1.02
Analysts	Strong Buy
Price Target	24.86 (+50.94%)
Earnings Date	Oct 28, 2025

About KIDS

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruct...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 12, 2017
• Employees: 562
• Stock Exchange: NASDAQ
• Ticker Symbol: KIDS
• Website: https://www.orthopediatrics.com

Financial Performance

In 2024, OrthoPediatrics's revenue was $204.73 million, an increase of 37.65% compared to the previous year's $148.73 million. Losses were -$37.82 million, 80.3% more than in 2023.

Analyst Summary

According to 7 analysts, the average rating for KIDS stock is "Strong Buy." The 12-month stock price target is $24.86, which is an increase of 50.94% from the latest price.

Price Target

$24.86

(50.94% upside)

Analyst Consensus: Strong Buy